Supercharge Your Innovation With Domain-Expert AI Agents!

Drug delivery compositions and methods

a technology of compositions and drugs, applied in the field of drug delivery compositions, can solve problems such as complex problems, inadequate cell proliferation, and potentially catastrophic consequences of infections

Inactive Publication Date: 2017-01-05
RAZAVI ALI DR
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

During this process, a wound site that is too moist or too dry may lead to inadequate cell proliferation.
Traditional bandages have been used in an effort to retain appropriate levels of moisture but are inadequate in many cases for a variety of reasons.
Additionally, bacteria are a significant concern during wound healing, as uncontrolled populations of bacteria, which naturally contaminate all wounds, may give rise to an infection with potentially catastrophic consequences.
This problem is complicated by the variety of bacteria which may be present, the increasing occurrence of drug-resistant bacteria, and patient drug allergies.
While bandages again have been used to keep additional contamination from reaching the wound, they are again largely ineffective in many cases and further have little or no impact on contamination existing prior to bandage application.
However, the amount of naturally occurring oxidative bursts is sometimes inadequate to quickly resolve contamination.
This leads to greater possibility of infection, particularly where environments having lesser or greater moisture undesirably result in slower healing.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug delivery compositions and methods
  • Drug delivery compositions and methods
  • Drug delivery compositions and methods

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0032]150 grams of potassium peroxymonosulfate triple salt were mixed with 5 g Lysine amino acid. This mixture was reacted with 100 g water in order to preferentially dissolve the K+HSO5− component out of the triple salt with immediate reaction with the amino acid, forming a slurry. This slurry was mechanically stirred in a glass beaker for a period of one hour. After one hour, the slurry mixture was vacuum filtered, and the resulting liquid material was collected and crystallized at room temperature. The crystallized powder materials were air dried to yield a dry powder base material. The powder base material was collected in a resealable plastic bag, and stored in a plastic bucket with anhydrous calcium sulfate desiccant material (Drierite®, W. A. Hammond Drierite Co. Ltd., Xenia, Ohio) placed in the bottom of the bucket. The bucket was closed with an air-tight lid. The activity of the triple salt proxy functional group decreased by less than 0.1% per month over the course of a ye...

example 2

[0034]150 grams of potassium peroxymonosulfate triple salt were mixed with 5 g Glutamine amino acid. This mixture was reacted with 100 g water in order to preferentially dissolve the K+HSO5− component out of the triple salt with immediate reaction with the amino acid, forming a slurry. This slurry was mechanically stirred in a glass beaker for a period of one hour. After one hour, the slurry mixture was vacuum filtered, and the resulting liquid material was collected and freeze dried to yield a powder base material. The powder base material was collected in a resealable plastic bag, and stored in a plastic bucket with anhydrous calcium sulfate desiccant material (Drierite®, W. A. Hammond Drierite Co. Ltd., Xenia, Ohio) placed in the bottom of the bucket. The bucket was closed with an air-tight lid. The activity of the triple salt proxy functional group decreased by less than 0.1% per month over the course of a year.

[0035]Referring to FIGS. 3A and B, differential scanning calorimetri...

example 3

[0036]150 grams of peroxymonosulfate triple salt were reacted with 100 g water in order to preferentially dissolve the K+HSO5− component out of the triple salt, forming a slurry. This slurry was mechanically stirred in a glass beaker for a period of one hour. After one hour, the slurry mixture was vacuum filtered, and the resulting liquid was reacted with 5 g Glycine amino acid. The reaction product was collected and freeze dried to yield a powder base material. The powder base material was collected in a resealable plastic bag, and stored in a plastic bucket with anhydrous calcium sulfate desiccant material (Drierite®, W. A. Hammond Drierite Co. Ltd., Xenia, Ohio) placed in the bottom of the bucket. The bucket was closed with an air-tight lid. The activity of the triple salt proxy functional group decreased by less than 0.01% per month over the course of a year.

Example 4

[0037]44 grams of peroxymonosulfate triple salt were reacted with 100 g water in order to preferentially dissolve...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
onset decomposition temperatureaaaaaaaaaa
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

A drug delivery composition is disclosed which includes a triple salt proxy functional group and at least one amino acid functional group. A method of forming the drug delivery composition includes reacting a triple salt with at least one amino acid in an aqueous environment. A biodegradable fabric is disclosed which includes a polymerized structure of a triple salt proxy functional group and at least one amino acid functional group.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of and claims the benefit of U.S. Non-patent application Ser. No. 14 / 675,836, filed Apr. 1, 2015, entitled “Drug Delivery Compositions and Methods,” which claims the benefit of U.S. Provisional Patent Application No. 61 / 973,903, filed Apr. 2, 2014, entitled “Drug Delivery Compositions and Methods,” the disclosures of both of which are incorporated by reference in their entirety and made part of the present U.S. utility patent application for all purposes.FIELD OF THE INVENTION[0002]This application is directed to drug delivery compositions and to methods for making and using the same, and more particularly to drug delivery compositions for wound treatment and to methods for making and using the same.BACKGROUND OF THE INVENTION[0003]The healing of a wound is a process that goes through a series of stages with varying cell types and chemical mediators in an appropriately moist environment. During this proc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K33/40A61L15/64A61L15/18A61K9/16A61L15/20A61K31/198A61L15/44
CPCA61K33/40A61K31/198A61L15/64A61L15/44A61L2300/404A61L15/20A61L15/18A61L2300/11A61L2300/214A61K9/16A61K9/0014A61K9/14A61P17/02A61K2300/00A61K31/16A61K9/7007
Inventor RAZAVI, ALI
Owner RAZAVI ALI DR
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More